| Application no. and date | 19163940.0 (espacenet) (Federated) (European Patent Register), 20111107 | | Patent/reg. no. and date | DK/EP 3539540, 20241218 | | Publication date | 20190918 | | Priority no. and date | EP 10190303, 20101108, EP 11151059, 20110117 | | EP pub. no. and date |
EP 3539540 20190918 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Strasse 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | P240048DKEP00 | | Inventor | KLEIN, Thomas, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Corporate
Patents
Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE,
MARK, Michael, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Corporate
Patents
Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE,
JOHANSEN, Odd-Erik, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, Corporate
Patents
Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE,
GREMPLER, Rolf, Boehringer Ingelheim International GmbH, Corporate
Patents
Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE,
LUIPPOLD, Gerd, Boehringer Ingelheim International GmbH, Corporate
Patents
Binger Strasse 173
55216 INGELHEIM AM RHEIN, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/341 (2006.01) , A61K 38/28 (2006.01) , A61P 3/10 (2006.01) | | Title | SGLT2-INHIBITOR 1-CHLOR-4-(BETA-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZEN I KOMBINATION MED INSULIN TIL ANVENDELSE I EN FREMGANGSMÅDE TIL REDUKTION AF RISIKOEN FOR HYPOGLYKÆMI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
